购物车
- 全部删除
- 您的购物车当前为空
Glucocorticoid receptor modulator 4 (Compound DL5) 结合了连接子和糖皮质激素受体调节剂的特性。在 K562 细胞中,该化合物通过GRE报告机制表达mTNF,具有EC50值为40μM的活性。此外,Glucocorticoid receptor modulator 4与抗肿瘤坏死因子(TNF)抗体相结合,在小鼠模型中展现了显著的抗关节炎抗炎效应。
Glucocorticoid receptor modulator 4 (Compound DL5) 结合了连接子和糖皮质激素受体调节剂的特性。在 K562 细胞中,该化合物通过GRE报告机制表达mTNF,具有EC50值为40μM的活性。此外,Glucocorticoid receptor modulator 4与抗肿瘤坏死因子(TNF)抗体相结合,在小鼠模型中展现了显著的抗关节炎抗炎效应。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Compound DL5, also known as Glucocorticoid receptor modulator 4, acts as a conjugate of linkers and glucocorticoid receptor regulators. It demonstrates GRE reporter activity in K562 cells expressing mTNF with an EC50 of 40 μM. Additionally, Compound DL5 binds to anti-tumor necrosis factor (TNF) antibodies and exhibits anti-inflammatory properties in combating arthritis in mouse models. |
分子量 | 826.72 |
分子式 | C37H43BrF3N3O8S |
CAS No. | 2688785-30-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容